{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:38:19Z","timestamp":1778837899447,"version":"3.51.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences","award":["BO\/00426\/11"],"award-info":[{"award-number":["BO\/00426\/11"]}]},{"name":"Internal Research Grant of University of Debrecen","award":["RH\/885\/2013"],"award-info":[{"award-number":["RH\/885\/2013"]}]},{"name":"Research Grant of University National, Research, Development and Innovation Office","award":["K 115818, 2015\/1"],"award-info":[{"award-number":["K 115818, 2015\/1"]}]},{"name":"IOIBD Research Grant","award":["2012-2015"],"award-info":[{"award-number":["2012-2015"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194166","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T13:54:59Z","timestamp":1522245299000},"page":"e0194166","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients"],"prefix":"10.1371","volume":"13","author":[{"given":"Gyorgy","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Sipeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boglarka","family":"Suga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakera","family":"Shums","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Antal-Szalmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3662-4010","authenticated-orcid":true,"given":"Maria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOG.0000000000000076","article-title":"Serological studies in inflammatory bowel disease: how important are they?","volume":"30","author":"M Papp","year":"2014","journal-title":"Current opinion in gastroenterology"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ajg.2010.505","article-title":"Serologic antiglycan antibodies in inflammatory bowel disease","volume":"106","author":"PL Lakatos","year":"2011","journal-title":"The American journal of gastroenterology"},{"issue":"Suppl 3","key":"ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000342603","article-title":"Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression?","volume":"30","author":"F Rieder","year":"2012","journal-title":"Digestive diseases (Basel, Switzerland)"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"B Terjung","year":"2010","journal-title":"Gut"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jhep.2013.04.018","article-title":"High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis","volume":"59","author":"M Papp","year":"2013","journal-title":"Journal of hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"640835","DOI":"10.1155\/2012\/640835","article-title":"Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn\u2019s disease","volume":"2012","author":"P Pavlidis","year":"2012","journal-title":"Clinical & developmental immunology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-407681-5.00006-4","article-title":"Glycoprotein 2 antibodies in Crohn\u2019s disease","volume":"60","author":"D Roggenbuck","year":"2013","journal-title":"Advances in clinical chemistry"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: a systematic review","volume":"18","author":"L Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12661","article-title":"Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis","volume":"30","author":"D Kevans","year":"2015","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/MIB.0000000000000466","article-title":"Predictors of Outcome in Ulcerative Colitis","volume":"21","author":"M Waterman","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.crohns.2007.10.001","article-title":"Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years","volume":"2","author":"O Hoie","year":"2008","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/00365529850166905","article-title":"Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients","volume":"33","author":"M Vecchi","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ibd.20781","article-title":"Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease","volume":"15","author":"IC Solberg","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/MIB.0b013e318281f2a1","article-title":"Serum antibodies associated with complex inflammatory bowel disease","volume":"19","author":"AA Elkadri","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjv087","article-title":"Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn\u2019s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]","volume":"9","author":"M Papp","year":"2015","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"22","key":"ref16","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.3748\/wjg.v21.i22.6952","article-title":"Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn\u2019s disease","volume":"21","author":"N Sipeki","year":"2015","journal-title":"World journal of gastroenterology: WJG"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"170","author":"JE Lennard-Jones","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"Suppl A","key":"ref18","doi-asserted-by":"crossref","first-page":"5a","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"MS Silverberg","year":"2005","journal-title":"Canadian journal of gastroenterology = Journal canadien de gastroenterologie"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"JD Lewis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"26","key":"ref20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"KW Schroeder","year":"1987","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","author":"A Dignass","year":"2012","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management","volume":"6","author":"A Dignass","year":"2012","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations","volume":"7","author":"G Van Assche","year":"2013","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management","volume":"11","author":"M Harbord","year":"2017","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders","volume":"11","author":"F Magro","year":"2017","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1128\/CVI.00002-09","article-title":"Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"16","author":"M Papp","year":"2009","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1097\/MIB.0000000000000564","article-title":"Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn\u2019s Disease","volume":"21","author":"MA Michaels","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ibd.21179","article-title":"Serum anti-glycan antibodies predict complicated Crohn\u2019s disease behavior: a cohort study","volume":"16","author":"F Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/ecco-jcc\/jjv127","article-title":"Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn\u2019s Disease","volume":"9","author":"PL Lakatos","year":"2015","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"10","key":"ref30","first-page":"1046","article-title":"Change in the extent of colonic involvement in ulcerative colitis: a colonoscopic study","volume":"82","author":"Y Niv","year":"1987","journal-title":"The American journal of gastroenterology"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0025-7125(16)30596-X","article-title":"Prognosis in Ulcerative Colitis","volume":"74","author":"O Brostr\u00f6m","year":"1990","journal-title":"Medical Clinics of North America"},{"issue":"4","key":"ref32","first-page":"211","article-title":"Change in the extent of idiopathic ulcerative proctocolitis","volume":"28","author":"G Riegler","year":"1996","journal-title":"The Italian journal of gastroenterology"},{"issue":"1","key":"ref33","first-page":"17","article-title":"Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up","volume":"17","author":"G Bresci","year":"1997","journal-title":"International journal of clinical pharmacology research"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1572-0241.1999.01145.x","article-title":"Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time","volume":"94","author":"B Moum","year":"1999","journal-title":"The American journal of gastroenterology"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00042737-199606000-00011","article-title":"Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression","volume":"8","author":"RC Ayres","year":"1996","journal-title":"European journal of gastroenterology & hepatology"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/00365529609004876","article-title":"Changes in extent of ulcerative colitis: a study on the course and prognostic factors","volume":"31","author":"E Langholz","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/ibd.20897","article-title":"Risk factors and characteristics of extent progression in ulcerative colitis","volume":"15","author":"MJ Etchevers","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/ajg.2009.177","article-title":"The natural history of pediatric ulcerative colitis: a population-based cohort study","volume":"104","author":"C Gower-Rousseau","year":"2009","journal-title":"The American journal of gastroenterology"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)","volume":"44","author":"IC Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"11\u201312","key":"ref40","first-page":"1334","article-title":"Corrigendum","volume":"42","year":"2015","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/apt.13307","article-title":"Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients","volume":"42","author":"E Safroneeva","year":"2015","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"ref42","article-title":"Long-term Extent Change of Pediatric-Onset Ulcerative Colitis","author":"F Rinawi","year":"2017","journal-title":"Journal of clinical gastroenterology"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/2050640616679552","article-title":"Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis","volume":"5","author":"S Sahami","year":"2017","journal-title":"United European gastroenterology journal"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4065\/71.5.431","article-title":"Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study","volume":"71","author":"WJ Sandborn","year":"1996","journal-title":"Mayo Clinic proceedings"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000201120","article-title":"Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens","volume":"55","author":"M Vecchi","year":"1994","journal-title":"Digestion"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2009.183095","article-title":"Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis","volume":"59","author":"CH Seow","year":"2010","journal-title":"Gut"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"e12957","DOI":"10.1371\/journal.pone.0012957","article-title":"Presence of anti-microbial antibodies in liver cirrhosis\u2014a tell-tale sign of compromised immunity?","volume":"5","author":"M Papp","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/gastro\/gou036","article-title":"Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk","volume":"2","author":"U Navaneethan","year":"2014","journal-title":"Gastroenterology report"},{"issue":"966","key":"ref49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/pgmj.2005.043901","article-title":"Management of inflammatory bowel diseases in Eastern Europe","volume":"82","author":"L Lakatos","year":"2006","journal-title":"Postgraduate medical journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:24:10Z","timestamp":1540247050000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194166"}},"subtitle":[],"editor":[{"given":"Matti","family":"Waterman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194166","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]}}}